Literature DB >> 26896741

p11 mediates the BDNF-protective effects in dendritic outgrowth and spine formation in B27-deprived primary hippocampal cells.

Sung Woo Park1, Le Hoa Nhu2, Hye Yeon Cho3, Mi Kyoung Seo3, Chan Hong Lee3, Nguyen Ngoc Ly2, Cheol Min Choi2, Bong Ju Lee4, Gyung-Mee Kim4, Wongi Seol5, Jung Goo Lee6, Young Hoon Kim7.   

Abstract

BACKGROUND: p11 (S100A10) is a key regulator of depression-like behaviors and antidepressant drug response in rodent models. Recent studies suggest that p11 mediates the behavioral antidepressant action of brain-derived neurotrophic factor (BDNF) in rodents. BDNF improves neural plasticity, which is linked to the cellular actions of antidepressant drugs. In the present study, we investigated whether p11 regulated BDNF action on neural plasticity in vitro.
METHODS: We generated primary hippocampal cultures. p11 expression, total dendritic length, and spine density were investigated under toxic conditions induced by B27 deprivation, which causes hippocampal cell death.
RESULTS: B27 deprivation significantly decreased p11 expression. Treatment with BDNF significantly prevented the B27 deprivation-induced decrease in p11 levels in a concentration-dependent manner, whereas these concentrations had no effect on control cultures. B27 deprivation significantly reduced the total length of hippocampal dendrites and spine density. BDNF increased the total dendritic length and spine density in conditions with or without B27. Furthermore, p11 knockdown through small interfering RNA (siRNA) transfection blocked these effects. The overexpression of p11 in B27-deprived cells increased the total dendritic length and spine density, and treatment with BDNF potentiated these effects. LIMITATION: This study should be confirmed in animal models of depression.
CONCLUSION: Taken together, our data suggest that BDNF-induced improvement in neural plasticity may depend on the regulation of p11 in hippocampal cells with B27 deprivation. These results provide evidence to strengthen the theoretical basis of a role for p11 in BDNF-induced antidepressant action.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BDNF; Hippocampus; Spine density; Total dendritic length; p11

Mesh:

Substances:

Year:  2016        PMID: 26896741     DOI: 10.1016/j.jad.2016.02.010

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  11 in total

1.  Galanin and Neuropeptide Y Interaction Enhances Proliferation of Granule Precursor Cells and Expression of Neuroprotective Factors in the Rat Hippocampus with Consequent Augmented Spatial Memory.

Authors:  Marina Mirchandani-Duque; Miguel A Barbancho; Alexander López-Salas; Jose Erik Alvarez-Contino; Natalia García-Casares; Kjell Fuxe; Dasiel O Borroto-Escuela; Manuel Narváez
Journal:  Biomedicines       Date:  2022-06-01

2.  HIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression.

Authors:  Pejman Rahimian; Johnny J He
Journal:  J Neuroinflammation       Date:  2016-09-15       Impact factor: 8.322

3.  P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy.

Authors:  Alexandra Neyazi; Wiebke Theilmann; Claudia Brandt; Tomi Rantamäki; Nobuaki Matsui; Mathias Rhein; Johannes Kornhuber; Malek Bajbouj; Wolfgang Sperling; Stefan Bleich; Helge Frieling; Wolfgang Löscher
Journal:  Transl Psychiatry       Date:  2018-01-22       Impact factor: 6.222

4.  AP-1 controls the p11-dependent antidepressant response.

Authors:  Revathy U Chottekalapanda; Salina Kalik; Jodi Gresack; Alyssa Ayala; Melanie Gao; Wei Wang; Sarah Meller; Ammar Aly; Anne Schaefer; Paul Greengard
Journal:  Mol Psychiatry       Date:  2020-05-21       Impact factor: 15.992

5.  Liraglutide Activates mTORC1 Signaling and AMPA Receptors in Rat Hippocampal Neurons Under Toxic Conditions.

Authors:  Sung Woo Park; Rodrigo B Mansur; Yena Lee; Jae-Hon Lee; Mi Kyoung Seo; Ah Jeong Choi; Roger S McIntyre; Jung Goo Lee
Journal:  Front Neurosci       Date:  2018-10-23       Impact factor: 4.677

6.  P11 Loss-of-Function is Associated with Decreased Cell Proliferation and Neurobehavioral Disorders in Mice.

Authors:  Guosheng Liu; Yabo Wang; Weixin Zheng; Hanhua Cheng; Rongjia Zhou
Journal:  Int J Biol Sci       Date:  2019-05-20       Impact factor: 6.580

7.  Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects.

Authors:  Ying Han; Cheng-Yu Sun; Shi-Qiu Meng; Serik Tabarak; Kai Yuan; Lu Cao; Wei Yan; Ling-Zhi Xu; Jia-Hui Deng; Wei-Li Zhu; Jia-Li Li; Lin Lu; Yan-Xue Xue; Jie Shi
Journal:  Mol Psychiatry       Date:  2019-08-02       Impact factor: 15.992

Review 8.  Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression.

Authors:  Marion J F Levy; Fabien Boulle; Harry W Steinbusch; Daniël L A van den Hove; Gunter Kenis; Laurence Lanfumey
Journal:  Psychopharmacology (Berl)       Date:  2018-06-30       Impact factor: 4.530

9.  BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response.

Authors:  Klaus Lieb; Nadine Dreimüller; Stefanie Wagner; Konrad Schlicht; Tanja Falter; Alexandra Neyazi; Linda Müller-Engling; Stefan Bleich; André Tadić; Helge Frieling
Journal:  Front Psychiatry       Date:  2018-10-26       Impact factor: 4.157

10.  Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.

Authors:  Atsushi Fujita; Hiroo Yamaguchi; Ryo Yamasaki; Yiwen Cui; Yuta Matsuoka; Ken-Ichi Yamada; Jun-Ichi Kira
Journal:  J Neuroinflammation       Date:  2018-08-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.